CN1391949A - 一种治疗胰腺癌的中药复方制剂 - Google Patents
一种治疗胰腺癌的中药复方制剂 Download PDFInfo
- Publication number
- CN1391949A CN1391949A CN 02136330 CN02136330A CN1391949A CN 1391949 A CN1391949 A CN 1391949A CN 02136330 CN02136330 CN 02136330 CN 02136330 A CN02136330 A CN 02136330A CN 1391949 A CN1391949 A CN 1391949A
- Authority
- CN
- China
- Prior art keywords
- chinese medicinal
- pancreas
- cancer
- compound chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 206010061902 Pancreatic neoplasm Diseases 0.000 title claims abstract description 27
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 208000008443 pancreatic carcinoma Diseases 0.000 title abstract description 10
- 201000002528 pancreatic cancer Diseases 0.000 title abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000006188 syrup Substances 0.000 claims abstract description 4
- 235000020357 syrup Nutrition 0.000 claims abstract description 4
- 239000003826 tablet Substances 0.000 claims abstract description 4
- 240000002943 Elettaria cardamomum Species 0.000 claims description 13
- 235000005300 cardamomo Nutrition 0.000 claims description 13
- 241000222336 Ganoderma Species 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 14
- 230000002401 inhibitory effect Effects 0.000 abstract description 14
- 210000000496 pancreas Anatomy 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 7
- 201000011510 cancer Diseases 0.000 abstract description 6
- 239000008187 granular material Substances 0.000 abstract description 5
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 2
- 241001127714 Amomum Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 240000005860 Portulaca grandiflora Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 230000004083 survival effect Effects 0.000 description 14
- 238000002512 chemotherapy Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 102000011759 adducin Human genes 0.000 description 4
- 108010076723 adducin Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 208000031648 Body Weight Changes Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 230000004596 appetite loss Effects 0.000 description 3
- 230000004579 body weight change Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000019017 loss of appetite Diseases 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 238000012820 exploratory laparotomy Methods 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241001312219 Amorphophallus konjac Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010062693 Gallbladder enlargement Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- 240000001659 Oldenlandia diffusa Species 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000915604 Scutellaria barbata Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009104 chemotherapy regimen Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000037230 mobility Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02136330 CN1225258C (zh) | 2002-08-01 | 2002-08-01 | 一种治疗胰腺癌的中药复方制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02136330 CN1225258C (zh) | 2002-08-01 | 2002-08-01 | 一种治疗胰腺癌的中药复方制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1391949A true CN1391949A (zh) | 2003-01-22 |
CN1225258C CN1225258C (zh) | 2005-11-02 |
Family
ID=4748602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02136330 Expired - Fee Related CN1225258C (zh) | 2002-08-01 | 2002-08-01 | 一种治疗胰腺癌的中药复方制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1225258C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071104A (zh) * | 2013-01-21 | 2013-05-01 | 戴玲玲 | 一种治疗中晚期胰腺癌的中药复方制剂 |
CN103800731A (zh) * | 2012-11-05 | 2014-05-21 | 复旦大学附属肿瘤医院 | 一种调控胰腺癌干细胞的中药复方制剂 |
CN104524420A (zh) * | 2015-01-31 | 2015-04-22 | 程君 | 一种局部晚期胰腺癌适形调强放疗增敏、减痛药物组合物 |
CN104667123A (zh) * | 2015-01-31 | 2015-06-03 | 程君 | 一种用于局部晚期胰腺癌三维适形调强放疗的中药组合物 |
CN105687823A (zh) * | 2016-01-28 | 2016-06-22 | 陈西成 | 胰腺癌患者化疗后服用的制剂及制法 |
CN105708929A (zh) * | 2016-03-31 | 2016-06-29 | 韩常英 | 胰腺癌患者放化疗期间服用的具有增效作用的制剂及制法 |
CN114887004A (zh) * | 2022-06-02 | 2022-08-12 | 复旦大学附属中山医院 | 一种用于治疗胰腺癌的中药组合物及其应用 |
-
2002
- 2002-08-01 CN CN 02136330 patent/CN1225258C/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103800731A (zh) * | 2012-11-05 | 2014-05-21 | 复旦大学附属肿瘤医院 | 一种调控胰腺癌干细胞的中药复方制剂 |
CN103071104A (zh) * | 2013-01-21 | 2013-05-01 | 戴玲玲 | 一种治疗中晚期胰腺癌的中药复方制剂 |
CN103071104B (zh) * | 2013-01-21 | 2015-01-07 | 戴玲玲 | 一种治疗中晚期胰腺癌的中药复方制剂 |
CN104524420A (zh) * | 2015-01-31 | 2015-04-22 | 程君 | 一种局部晚期胰腺癌适形调强放疗增敏、减痛药物组合物 |
CN104667123A (zh) * | 2015-01-31 | 2015-06-03 | 程君 | 一种用于局部晚期胰腺癌三维适形调强放疗的中药组合物 |
CN104524420B (zh) * | 2015-01-31 | 2018-07-06 | 青岛市肿瘤医院 | 一种局部晚期胰腺癌适形调强放疗增敏、减痛药物组合物 |
CN104667123B (zh) * | 2015-01-31 | 2019-03-12 | 青岛市肿瘤医院 | 一种用于局部晚期胰腺癌三维适形调强放疗的中药组合物及其应用 |
CN105687823A (zh) * | 2016-01-28 | 2016-06-22 | 陈西成 | 胰腺癌患者化疗后服用的制剂及制法 |
CN105708929A (zh) * | 2016-03-31 | 2016-06-29 | 韩常英 | 胰腺癌患者放化疗期间服用的具有增效作用的制剂及制法 |
CN114887004A (zh) * | 2022-06-02 | 2022-08-12 | 复旦大学附属中山医院 | 一种用于治疗胰腺癌的中药组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1225258C (zh) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101947284B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN101612357B (zh) | 一种治疗肿瘤的中药组合物及其制备方法 | |
CN101711848B (zh) | 一种辅助治疗肿瘤的中药组合物 | |
CN101091769B (zh) | 一种治疗和预防食道癌、胃癌的药物及其制备方法 | |
CN102764371B (zh) | 一种减轻放疗副反应的中药复方及其制备方法和应用 | |
CN1225258C (zh) | 一种治疗胰腺癌的中药复方制剂 | |
CN1733242A (zh) | 一种治疗气虚血瘀型胸痹(冠心病)的药物及其制备工艺 | |
CN108186794B (zh) | 一种治疗肺癌的中药组合物及其制备方法和应用 | |
CN102028924B (zh) | 一种用于晚期胃癌的药物组合物 | |
CN101391004B (zh) | 一种用于晚期食管癌的药物组合物 | |
CN101007159B (zh) | 防治肿瘤的中药 | |
CN105770263A (zh) | 一种肿瘤辅助治疗的中药制剂及其制备方法 | |
CN104352603A (zh) | 一种增强人体免疫力的抗肿瘤中药 | |
CN1990033A (zh) | 一种治疗高血压、血稠、动脉硬化的药物 | |
CN100584351C (zh) | 一种抗癌药及其制备方法 | |
CN103417911A (zh) | 化疗辅助用中药组合物 | |
CN103948859A (zh) | 一种抗肿瘤中药复方制剂及其制备方法和应用 | |
CN104127684A (zh) | 一种治疗癌症的中药复方制剂 | |
CN103349709B (zh) | 一种益气养阴、滋补肝肾的中药制剂 | |
CN102836315A (zh) | 一种预防调理转归肿瘤的中药组合物及其制备方法 | |
CN103768519B (zh) | 一种提高环磷酰胺抗肿瘤疗效的复方药物及其制备方法 | |
CN101007114B (zh) | 一种肿瘤患者辅助用药品或保健品及其制备方法 | |
CN1185006C (zh) | 一种辅助治疗原发性肝癌的中药组合物及其制备方法 | |
CN113230379B (zh) | 一种用于治疗腹部肿瘤手术后胃瘫综合征的理气消痞汤 | |
CN1092972C (zh) | 一种抗肿瘤及抗癌转移的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SAIDE BIOLOGICAL STOCKS CO., LTD., SHANGHAI CITY Free format text: FORMER OWNER: TUMOR HISPITAL ATTACHED TO FUDAN UNIV. Effective date: 20041015 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20041015 Address after: 201203, Zhangjiang Road, Zhangjiang, Pudong, No. 1, Curie Road, Shanghai Applicant after: Shanghai Celstar Bio-pharmaceutical Holding Co., Ltd. Address before: 200032 No. 270, Dongan Road, Shanghai Applicant before: Tumor Hispital Attached to Fudan Univ. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TUMOR HISPITAL ATTACHED TO FUDAN UNIV. Free format text: FORMER OWNER: SAIDE BIOLOGICAL STOCKS CO., LTD., SHANGHAI CITY Effective date: 20080215 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080215 Address after: No. 270, Dongan Road, Shanghai Patentee after: Tumor Hispital Attached to Fudan Univ. Address before: No. 1 Curie Road, Zhangjiang, Shanghai, Pudong Patentee before: Shanghai Celstar Bio-pharmaceutical Holding Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051102 Termination date: 20190801 |
|
CF01 | Termination of patent right due to non-payment of annual fee |